Raymond James Starts Coverage on Bank of N.T. Butterfield & Son (CVE:NTB) Stock With Outperform Rating, $28.0 Target Price per Share

Share with your friends










Submit

Raymond James Bank of N.T. Butterfield & Son CVE:NTB

Bank of N.T. Butterfield & Son (CVE:NTB) Price Target & New Coverage by Raymond James

Research professionals at Raymond James has started coverage on shares of Bank of N.T. Butterfield & Son (CVE:NTB) in a note sent to clients and investors on Tuesday morning. The broker set Outperform rating on the stock. Raymond James’s price target of $28.0 suggests potential of 9.33 % from the stock’s last close price.

In spite of the new coverage CVE:NTB is at the moment trading 0.00% lower at $0.00 as of 04:03 New York time. Bank of N.T. Butterfield & Son shares have risen 35.25% in the last 200 days, while the S&P 500 has added 4.81% in the same time period.

CVE:NTB Price Chart & Trend

The stock price of Bank of N.T. Butterfield & Son has gained 35.25% over the last 200 days, and is in energetic up trend. In the last 50 and 100 days, Bank of N.T. Butterfield & Son is up 33.33% and up 38.24%, respectively. Our stocks momentum model is shown on the price chart below.Raymond James Starts Coverage on Bank of N.T. Butterfield amp; Son (CVE:NTB) Stock With Outperform Rating, $28.0 Target Price per Share

Source: RightEdge Systems, Yahoo Split & Dividend Adjusted Data and OctaFinance Trading Models

NTB Stock Chart

Bank of N.T. Butterfield & Son (CVE:NTB) Profile

Neptune Technologies & Bioressources Inc. is a solution provider of omega-3’s and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. The Company is engaged in the development, manufacture and commercialization of marine-derived omega-3 fatty acids. The Company’s products include Krill-Based Nutraceutical Products, including Neptune Krill Oil (NKO), OCEANO3, Formulations Derived from NKO and Neptune Krill Aquatein (NKA); Other Nutraceutical Products, and Pharmaceutical Product Candidate (CaPre)-Acasti.

Bank of N.T. Butterfield & Son (CVE:NTB) closed at $0 yesterday. A total of shares of the company’s stock traded hands. This is down from average of 31,215 shares. Bank of N.T. Butterfield & Son has a 52 week low of $2.01 and a 52 week high of $4.46. The company has a market cap of $147.24M and a P/E ratio of 0.

Get the latest Bank of N.T. Butterfield & Son (CVE:NTB) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.

Bank of N.T. Butterfield & Son - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.